Revenue
Breakdown
Segments
ProductView metric
RoyaltyView metric
Pfizer CentreOneView metric
EliquisView metric
Prevnar FamilyView metric
Nurtec ODT/VyduraView metric
ComirnatyView metric
PaxlovidView metric
AbrysvoView metric
FSME-IMMUN/TicoVacView metric
All other Primary CareView metric
IbranceView metric
PadcevView metric
XtandiView metric
LorbrenaView metric
InlytaView metric
AdcetrisView metric
Braftovi/MektoviView metric
BosulifView metric
TukysaView metric
OrgovyxView metric
ElrexfioView metric
TalzennaView metric
TivdakView metric
All other OncologyView metric
Vyndaqel familyView metric
XeljanzView metric
Zavicefta (Outside the U.S. and Canada)View metric
Enbrel (Outside the U.S. and Canada)View metric
OctagamView metric
GenotropinView metric
CibinqoView metric
All other Specialty CareView metric
Oncology BiosimilarsView metric
Sulperazon (Outside the U.S. and Canada)View metric
InflectraView metric
ZithromaxView metric
All Other Hospital and BiosimilarsView metric
Excluding Comirnaty and PaxlovidView metric